Hematopoietic Stem Cell Mobilization: Clinical Trials

7 trials for Hematopoietic Stem Cell Mobilization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 2 unknown, 1 completed. 3 Phase 3, 2 Not applicable, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Not yet recruiting 1
Not applicable2Not yet recruiting 1, Unknown 1
Phase 22Not yet recruiting 1, Unknown 1
Phase 11Unknown 1

Follow Hematopoietic Stem Cell Mobilization: new trials by email Literature Review of Hematopoietic Stem Cell Mobilization trials Research Report on Hematopoietic Stem Cell Mobilization

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell Mobilization
rhTPO prophylaxis plus EAP stem-cell mobilization - Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Hematopoietic Stem Cell Mobilization
Phase 2 / Phase 3Not yet recruitingThe Affiliated People's Hospital of Ningbo University702027-01-012026-09-30
Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia
Recombinant Human Thrombopoietin(rhTPO) - Hematopoietic Stem Cell Mobilization
Not applicableNot yet recruitingInstitute of Hematology & Blood Diseases Hospital, China602025-05-302025-05-02
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Etoposide, Cytarabine, PEG-rhG-CSF - Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
Phase 3RecruitingThe Affiliated People's Hospital of Ningbo University992024-08-012025-12-04
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Etoposide, Cytarabine, Pegfilgrastim - Multiple Myeloma, Hematopoietic Stem Cell Mobilization
Phase 3RecruitingThe Affiliated People's Hospital of Ningbo University992024-08-012024-07-25
Evaluation of Plant-based Nutritional Products on Stem Cells
Berry extract I, Berry Extract II, Berry extract blend - Stem Cell Mobilization, Hematopoietic Stem Cell Mobilization
Not applicableUnknownNatural Immune Systems Inc242018-01-302019-03-13
Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
Recombinant Human Thrombopoietin - Thrombocytopoietin, Hematopoietic Stem Cell Mobilization
Phase 1 / Phase 2UnknownHongnan Mo502016-06-012019-12-06
Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors
Hematopoietic Stem Cell Mobilization
CompletedSandoz2452011-05-012024-09-19

Narrower conditions

Multiple Myeloma (2)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Blood Protein Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Lymphatic Diseases (2)  ·  Neoplasms, Plasma Cell (2)  ·  Paraproteinemias (2)  ·  Vascular Diseases (2)

Interventions

Cytarabine (2)  ·  Etoposide (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  pegylated granulocyte colony-stimulating factor (2)  ·  1-(1-glycero)dodeca-1,3,5,7,9-pentaene (1)  ·  CVAD protocol (1)  ·  Cyclophosphamide (1)  ·  EPOCH protocol (1)  ·  Guanosine Diphosphate (1)  ·  Ice (1)  ·  Thrombopoietin (1)  ·  pegfilgrastim (1)

Sponsors

The Affiliated People's Hospital of Ningbo University (3)  ·  Hongnan Mo (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Natural Immune Systems Inc (1)  ·  Sandoz (1)

Countries

China (4)  ·  Germany (1)  ·  United States (1)

Top investigators

Gitte Jensen (1)  ·  Hexal AG (1)  ·  Peipei Ye (1)  ·  Ying Lu (1)

Results publications

PMID 34505019, PMID 35287672